Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Redefining lactose as a conditional prebiotic.

Andrew Szilagyi1

  • 1McGill University School of Medicine, The Sir Mortimer B, Davis-Jewish General Hospital, Montreal, Quebec. aszilagy@gas.jgh.mcgill.ca

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|April 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome alternative treatments for hepatic encephalopathy: Reassessment of the potential use of lactose in lactase non-persistent cirrhosis patients.

Canadian liver journal·2026
Same author

There may be a differential mechanistic impact on colorectal cancer of lactose-containing foods between lactase persistent and lactase non-persistent populations.

Frontiers in nutrition·2026
Same author

Response.

Canadian family physician Medecin de famille canadien·2025
Same author

Dietary Relationships between Obesity and Inflammatory Bowel Diseases: A Narrative Review of Diets Which May Promote Both Diseases.

Current gastroenterology reports·2025
Same author

Approach to steatotic liver disease in the office: Diagnosis, management, and proposed nomenclature.

Canadian family physician Medecin de famille canadien·2025
Same author

Approche de la stéatose hépatique en clinique: Diagnostic, prise en charge et nomenclature proposée.

Canadian family physician Medecin de famille canadien·2025

Lactose maldigestion affects many globally, often causing IBS-like symptoms. However, lactose may act as a prebiotic, benefiting gut health in individuals with lactase non-persistence.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Nutritional Science

Background:

  • Lactose maldigestion impacts 70-75% of the global population, leading to symptoms similar to Irritable Bowel Syndrome (IBS).
  • Current research primarily focuses on improving lactose tolerance for enhanced dairy nutrition.
  • The role of lactose and its maldigestion in gut health, particularly as a prebiotic, remains underexplored.

Purpose of the Study:

  • To reassess the role of lactose as a potential prebiotic in individuals with lactase non-persistence.
  • To examine the scientific and clinical evidence supporting lactose's prebiotic properties.
  • To evaluate lactose's potential benefits beyond nutrition in the context of gut microbiota interactions.

Main Methods:

  • Review of existing scientific and clinical literature on lactose properties and function.

Related Experiment Videos

  • Analysis of lactose's characteristics against established prebiotic criteria (Gibson and Roberfroid).
  • Examination of host-microfloral interactions in subjects with lactase non-persistence.

    • Main Results:

    • Lactose maldigestion is widespread, contributing to gastrointestinal discomfort.
    • Evidence suggests lactose can serve as a substrate for beneficial gut bacteria.
    • Lactose meets key criteria to be classified as a prebiotic in specific populations.

    Conclusions:

    • Lactose possesses properties that qualify it as a prebiotic for individuals with lactase non-persistence.
    • Further research into lactose's prebiotic effects could offer novel therapeutic strategies for gut health.
    • Re-evaluating lactose's role is crucial given advancements in understanding gut microbiota and probiotics.